LXEO

Conviction 20HealthcareScan · Thu, Jun 25, 2026

LXEO$4.70-3.99%

ResistanceSupportVol 14Insider sell

Vol MA14 1.07M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Lexeo Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.lexeotx.com ↗

Price4.70

Change-3.99%

Gap-0.51%

Rel volume3.12×

Avg volume944.57K

Avg $ vol4.46M

SMA 204.66

SMA 505.32

SMA 2007.14

Price vs 50-11.67%

Price vs 200-34.27%

MA stackbearish

50/200 cross—

Supertrenddown · 5.19

RSI (14)45

MACD hist0.09

MACD crossbull · 7d

Stoch %K / %D51 / 61

ADX (14)18

+DI / −DI26 / 20

RSI divergenceBullish

MACD divergenceBullish

ATR %+7.69%

ADR %7.15%

52w high10.63

52w low3.67

From 52w high-55.83%

Above 52w low+27.93%

New 52w highNo

SqueezeOff

Bollinger width27.02%

%B0.53

Donchian pos50.76%

Donchian high5.34

Donchian low4.03

AVWAP (52w high)6.55

vs AVWAP high-28.30%

AVWAP (52w low)7.40

vs AVWAP low-36.53%

OBV trendFlat

Chaikin MF (20)-0.39

Today vs 20d3.12×

Avg vol (14d)1.07M

Avg vol (20d)944.57K

Avg $ vol (20d)4.46M

Market cap368.66M

RS 3m (vs SPY)-23.35%

RS 6m (vs SPY)-60.49%

RS line new highNo

Trend template0/8

Technical rank12.1

1 week-5.72%

1 month-8.66%

3 months-17.92%

6 months-55.83%

1 year+11.52%

YTD-51.14%

P/E-3.69

P/B1.59

P/S563.70

P/FCF-3.73

EPS-1.86

Div yield—

ROE-43.18%

ROA-39.93%

Debt/Eq—

Current14.16

EV/EBITDA-2.72

Gross margin—

Net margin—

Rev growth—

EPS growth-1.66%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value296.89M

Revenue531K

Net income-20.2M

Gross profit—

Free cash flow-98.96M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out78.52M

Employees59

ListedFri, Nov 3, 2023

Free float76.64M

Float %97.6%

Short interest13.78M

Days to cover17.4d

Short volume88.9%

Squeeze score96 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank12.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.92

Support4.23

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LXEO

All disclosures →

No recent disclosed trades by Congress in LXEO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LXEO · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Townsend Richard Nolan Chief Executive Officer · Common Stock · 2026-05-18	Sell	3.34K	$17K	2026-05-18	2026-05-20
Otero Jose Manuel Chief Operating Officer · Common Stock · 2026-05-18	Sell	1.3K	$7K	2026-05-18	2026-05-20

SEC filings

EDGAR filings in LXEO · 1 recent

EDGAR →

8-K8-KMon, Jun 15, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.